Livaform

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Cynara scolymus, Quantity: 15 mg (Equivalent: Cynara scolymus, Qty 750 mg; Equivalent: Caffeoylquinic acids calculated as cynarin of Cynara scolymus, Qty 750 microgram); Silybum marianum, Quantity: 156.29 mg (Equivalent: Silybum marianum, Qty 10.94 g; Equivalent: Flavanolignans calculated as silybin, Qty 125 mg); d-alpha-tocopheryl acid succinate, Quantity: 27.5 mg (Equivalent: d-alpha-tocopheryl acid succinate, Qty 33 IU); taurine, Quantity: 50 mg; Schisandra chinensis, Quantity: 150 mg (Equivalent: Schisandra chinensis, Qty 750 mg)

Available from:

Pharmametics Products A Division of Max Biocare Pty Ltd

INN (International Name):

Cynara scolymus,d-alpha-Tocopheryl acid succinate,Schisandra chinensis,Silybum marianum,Taurine

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: magnesium stearate; povidone; microcrystalline cellulose; crospovidone; maltodextrin; calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; croscarmellose sodium; titanium dioxide; purified talc; triethyl citrate; sodium lauryl sulfate; methacrylic acid copolymer; sodium bicarbonate; macrogol 4000; polyvinyl alcohol; quinoline yellow aluminium lake; carmoisine aluminium lake; lecithin; indigo carmine aluminium lake

Administration route:

Oral

Therapeutic indications:

Antioxidant/Reduce free radicals formed in the body ; Helps reduce/decrease free radical damage to body cells ; Aids/assists natural body cleansing/detoxification processes ; Maintain/support natural liver cleansing/detoxification processes ; Helps improve/promote body metabolism/metabolic rate ; Maintain/support general health and wellbeing ; Maintain/support healthy digestive system function ; Maintain/support healthy liver function ; Maintain/support liver health

Product summary:

Visual Identification: ;

Authorization status:

Licence status A

Authorization date:

2016-09-23